APA
Blake J. F., Burkard M., Chan J., Chen H., Chou K., Diaz D., Dudley D. A., Gaudino J. J., Gould S. E., Grina J., Hunsaker T., Liu L., Martinson M., Moreno D., Mueller L., Orr C., Pacheco P., Qin A., Rasor K., Ren L., Robarge K., Shahidi-Latham S., Stults J., Sullivan F., Wang W., Yin J., Zhou A., Belvin M., Merchant M., Moffat J. & Schwarz J. B. (20170609). Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development. : Journal of medicinal chemistry.
Chicago
Blake James F, Burkard Michael, Chan Jocelyn, Chen Huifen, Chou Kang-Jye, Diaz Dolores, Dudley Danette A, Gaudino John J, Gould Stephen E, Grina Jonas, Hunsaker Thomas, Liu Lichuan, Martinson Matthew, Moreno David, Mueller Lars, Orr Christine, Pacheco Patricia, Qin Ann, Rasor Kevin, Ren Li, Robarge Kirk, Shahidi-Latham Sheerin, Stults Jeffrey, Sullivan Francis, Wang Weiru, Yin Jianping, Zhou Aihe, Belvin Marcia, Merchant Mark, Moffat John and Schwarz Jacob B. 20170609. Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development. : Journal of medicinal chemistry.
Harvard
Blake J. F., Burkard M., Chan J., Chen H., Chou K., Diaz D., Dudley D. A., Gaudino J. J., Gould S. E., Grina J., Hunsaker T., Liu L., Martinson M., Moreno D., Mueller L., Orr C., Pacheco P., Qin A., Rasor K., Ren L., Robarge K., Shahidi-Latham S., Stults J., Sullivan F., Wang W., Yin J., Zhou A., Belvin M., Merchant M., Moffat J. and Schwarz J. B. (20170609). Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development. : Journal of medicinal chemistry.
MLA
Blake James F, Burkard Michael, Chan Jocelyn, Chen Huifen, Chou Kang-Jye, Diaz Dolores, Dudley Danette A, Gaudino John J, Gould Stephen E, Grina Jonas, Hunsaker Thomas, Liu Lichuan, Martinson Matthew, Moreno David, Mueller Lars, Orr Christine, Pacheco Patricia, Qin Ann, Rasor Kevin, Ren Li, Robarge Kirk, Shahidi-Latham Sheerin, Stults Jeffrey, Sullivan Francis, Wang Weiru, Yin Jianping, Zhou Aihe, Belvin Marcia, Merchant Mark, Moffat John and Schwarz Jacob B. Discovery of (S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one (GDC-0994), an Extracellular Signal-Regulated Kinase 1/2 (ERK1/2) Inhibitor in Early Clinical Development. : Journal of medicinal chemistry. 20170609.